Butabarbital decreases results of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Intently. Coadministration of CYP3A4 inducers could decrease sufentanil levels and efficacy, perhaps precipitating withdrawal syndrome in people who have formulated Bodily dependence to sufentanil. Discontinuation of concomitantly utilized CYP3A4 ind... https://moseleyb554rbf0.wikiannouncing.com/user